tiprankstipranks
Trending News
More News >
MaxCyte Inc (GB:MXCT)
LSE:MXCT

MaxCyte (MXCT) Similar Shares

Compare
9 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
MaxCyte
189.50p
£203.28M
-40.48%
5 Buy
0 Hold
0 Sell
Strong Buy
Sangamo Biosciences
$0.71
$147.52M
26.07%
5 Buy
2 Hold
0 Sell
Moderate Buy
Editas Medicine
$1.00
$85.47M
-85.42%
3 Buy
5 Hold
1 Sell
Hold
Intellia Therapeutics
$6.54
$686.32M
-74.15%
15 Buy
4 Hold
1 Sell
Moderate Buy
Crispr Therapeutics AG
$32.38
$2.81B
-49.48%
12 Buy
6 Hold
1 Sell
Moderate Buy
Beam Therapeutics
$15.30
$1.52B
-49.53%
12 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:MXCT
MaxCyte
197.00
-133.00
-40.30%
SGMO
Sangamo Biosciences
0.71
0.15
26.79%
EDIT
Editas Medicine
0.98
-6.03
-86.02%
NTLA
Intellia Therapeutics
6.54
-19.54
-74.92%
CRSP
Crispr Therapeutics AG
32.38
-32.81
-50.33%
BEAM
Beam Therapeutics
14.54
-14.78
-50.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis